{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:11:50Z","timestamp":1648703510813},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00347-019-00964-y","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T14:02:46Z","timestamp":1576504966000},"page":"566-570","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tyrosinkinaseinhibitor-assoziierte Choroidopathie"],"prefix":"10.1007","volume":"117","author":[{"given":"C.","family":"Schober","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fiorentzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Viestenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"964_CR1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/02713680601013025","volume":"31","author":"M Campbell","year":"2006","unstructured":"Campbell\u00a0M, Collery\u00a0R, McEvoy\u00a0A et al (2006) Involvement of MAPKs in endostatinmediated regulation of blood-retinal barrier function. Curr Eye Res 31:1033\u20131045. https:\/\/doi.org\/10.1080\/02713680601013025","journal-title":"Curr Eye Res"},{"issue":"Suppl 1","key":"964_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12886-018-0861-8","volume":"18","author":"P Tyagi","year":"2018","unstructured":"Tyagi\u00a0P, Santiago\u00a0C (2018) New features in MEK retinopathy. BMC Ophthalmol 18(Suppl 1):221. https:\/\/doi.org\/10.1186\/s12886-018-0861-8","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"964_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00347-016-0226-8","volume":"113","author":"I Ludeke","year":"2016","unstructured":"Ludeke\u00a0I, Terheyden\u00a0P, Grisanti\u00a0S, Luke\u00a0M (2016) Development of serous retinopathy during therapy of a\u00a0metastatic cutaneous melanoma. Ophthalmologe 113(10):861\u2013863. https:\/\/doi.org\/10.1007\/s00347-016-0226-8","journal-title":"Ophthalmologe"},{"key":"964_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12348-015-0049-9","volume":"5","author":"D Draganova","year":"2015","unstructured":"Draganova\u00a0D, Kerger\u00a0J, Caspers\u00a0L, Willermain\u00a0F (2015) Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib. J\u00a0Ophthalmic Inflamm Infect 5:17. https:\/\/doi.org\/10.1186\/s12348-015-0049-9","journal-title":"J Ophthalmic Inflamm Infect."},{"key":"964_CR5","volume-title":"CCs-artige Retinopathie in der Therapie des malignen Melanoms: Korrelation mit kumulativer Dosis oder Stadium der Erkrankung?","author":"J Abbasova","year":"2016","unstructured":"Abbasova\u00a0J, Siedlecki\u00a0J, Bayerl-L\u00f6he\u00a0K, Priglinger\u00a0S, Berking\u00a0C, Eibl-Lindner\u00a0K (2016) CCs-artige Retinopathie in der Therapie des malignen Melanoms: Korrelation mit kumulativer Dosis oder Stadium der Erkrankung? https:\/\/www.dog.org\/wp-content\/uploads\/2016\/09\/Abbasova-DOG-2016.pdf. Zugegriffen: 15.12.2019"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-019-00964-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T01:22:08Z","timestamp":1607995328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-019-00964-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1007\/s00347-019-00964-y","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]},"assertion":[{"value":"16 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Schober, J.M.\u00a0Beyer, M.\u00a0Fiorentzis und A.\u00a0Viestenz geben an, dass kein Interessenkonflikt besteht. Die korrespondierende Autorin versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Pr\u00e4sentation des Themas ist unabh\u00e4ngig und die Darstellung der Inhalte produktneutral.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}